Evaluation of the Vitek-2 extended-spectrum β-lactamase test against non-duplicate strains of Enterobacteriaceae producing a broad diversity of well-characterised β-lactamases

Clinical Microbiology and Infection

Volumn 14, Issue 2, 2008, Pages 148-154

  Robin, F ^a   Delmas, J ^a   Schweitzer, C ^a   Bonnet, R ^a  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

Detection; Enterobacteriaceae; Extended spectrum lactamases; Phenotypic test; Synergy test; Vitek 2 ESBL test

Indexed keywords

BETA LACTAMASE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE;

ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOANALYSIS; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; ENTEROBACTERIACEAE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SENSITIVITY AND SPECIFICITY;

ENTEROBACTERIACEAE; ESCHERICHIA COLI;

EID: 38049093010     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2007.01893.x     Document Type: Article

References (24)

1. Livermore DM. β-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995; 8: 557-584.
2. Bradford PA. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14: 933-951.
3. Paterson DL. Resistance in gram-negative bacteria: Enterobacteriaceae. Am J Infect Control 2006; 34: S20-S28.
4. Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: A clinical update. Clin Microbiol Rev 2005; 18: 657-686.
5. Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 15th informational supplement, M100-S15. Wayne, PA: CLSI, 2006.
6. Bonnet R, Sampaio JL, Chanal C et al. A novel classA extended-spectrum β-lactamase (BES-1) in Serratia marcescens isolated in Brazil. Antimicrob Agents Chemother 2000; 44: 3061-3068.
7. De Champs C, Chanal C, Sirot D et al. Frequency and diversity of classA extended-spectrum beta-lactamases in hospitals of the Auvergne, France: a 2 year prospective study. J Antimicrob Chemother 2004; 54: 634-639.
8. Deshpande LM, Rhomberg PR, Sader HS, Jones RN. Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in United States medical centers: Report from the MYSTIC program (1999-2005). Diagn Microbiol Infect Dis 2006; 56: 367-372.
9. Wachino J, Doi Y, Yamane K et al. Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel classA beta-lactamase, GES-3, in a neonatal intensive care unit in Japan. Antimicrob Agents Chemother 2004; 48: 1960-1967.
10. Spanu T, Sanguinetti M, Tumbarello M et al. Evaluation of the new VITEK2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates. J Clin Microbiol 2006; 44: 3257-3262.
11. Tzelepi E, Giakkoupi P, Sofianou D, Loukova V, Kemeroglou A, Tsakris A. Detection of extended-spectrum beta-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes. J Clin Microbiol 2000; 38: 542-546.
12. Sturenburg E, Lang M, Horstkotte MA, Laufs R, Mack D. Evaluation of the Microscan ESBL plus confirmation panel for detection of extended-spectrum beta-lactamases in clinical isolates of oxyimino-cephalosporin-resistant gram-negative bacteria. J Antimicrob Chemother 2004; 54: 870-875.
13. Sturenburg E, Sobottka I, Noor D, Laufs R, Mack D. Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection. J Antimicrob Chemother 2004; 54: 134-138.
14. Gottlieb T, Wolfson C. Comparison of the MICs of cefepime for extended-spectrum beta-lactamase-producing and non-extended-spectrum beta-lactamase-producing strains of Enterobacter cloacae. J Antimicrob Chemother 2000; 46: 330-331.
15. Yu WL, Wu LT, Pfaller MA, Winokur PL, Jones RN. Confirmation of extended-spectrum beta-lactamase-producing Serratia marcescens: preliminary report from Taiwan. Diagn Microbiol Infect Dis 2003; 45: 221-224.
16. Mammeri H, Laurans G, Eveillard M, Castelain S, Eb F. Coexistence of SHV-4- and TEM-24-producing Enterobacter aerogenes strains before a large outbreak of TEM-24-producing strains in a French hospital. J Clin Microbiol 2001; 39: 2184-2190.
17. Vercauteren E, Descheemaeker P, Ieven M, Sanders CC, Goossens H. Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital. J Clin Microbiol 1997; 35: 2191-2197.
18. M'Zali FH, Chanawong A, Kerr KG, Birkenhead D, Hawkey PM. Detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae: Comparison of the MAST DD test, the double disc and the Etest ESBL. J Antimicrob Chemother 2000; 45: 881-885.
19. Linscott AJ, Brown WJ. Evaluation of four commercially available extended-spectrum beta-lactamase phenotypic confirmation tests. J Clin Microbiol 2005; 43: 1081-1085.
20. Robin F, Delmas J, Archambaud M, Schweitzer C, Chanal C, Bonnet R. CMT-type β-lactamase TEM-125, an emerging problem for extended spectrum β-lactamase detection. Antimicrob Agents Chemother 2006; 50: 2043-2048.
21. Poirel L, Mammeri H, Nordmann P. TEM-121, a novel complex mutant of TEM-type β-lactamase from Enterobacter aerogenes. Antimicrob Agents Chemother 2004; 48: 4528-4531.
22. Robin F, Delmas J, Schweitzer C et al. Evolution of TEM-type enzymes: biochemical and genetic characterization of two new complex mutant TEM enzymes, TEM-151 and TEM-152, from a single patient. Antimicrob Agents Chemother 2007; 51: 1304-1309.
23. Thomson KS, Cornish NE, Hong SG, Hemrick K, Herdt C, Moland ES. Comparison of Phoenix and Vitek 2 ESBL detection tests against E. coli and Klebsiella isolates with well-characterized β-lactamases. J Clin Microbiol 2007; 45: 2380-2384.
24. Sanders CC, Barry AL, Washington JA et al. Detection of extended-spectrum-beta-lactamase-producing members of the family Enterobacteriaceae with Vitek ESBL test. J Clin Microbiol 1996; 34: 2997-3001.